| Income Statement |
| Operating Expenses | 7.82M |
|
| Research and Development Expense | 3.34M |
| Selling, General and Administrative Expense | 6.87M |
| Operating Income | -7.82M |
| Net Income | -7.82M |
| Net Income Common Stock | -7.82M |
| Net Income Common Stock (USD) | -7.82M |
| Consolidated Income | -7.82M |
| Earnings per Basic Share | -2.44 |
| Earnings per Basic Share (USD) | -2.44 |
| Earnings per Diluted Share | -2.44 |
| Earning Before Interest & Taxes (EBIT) | -7.82M |
| Earning Before Interest & Taxes (USD) | -7.82M |
| Weighted Average Shares | 3.21M |
| Weighted Average Shares Diluted | 3.21M |
| Balance Sheet |
| Cash and Equivalents | 24.16M |
| Cash and Equivalents (USD) | 24.16M |
| Current Assets | 25.18M |
| Total Assets | 25.18M |
| Current Liabilities | 20.72M |
| Total Liabilities | 20.72M |
| Accumulated Retained Earnings (Deficit) | -720.14M |
| Shareholders Equity | 4.46M |
| Shareholders Equity (USD) | 4.46M |
| Trade and Non-Trade Payables | 902.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 25.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.18M |
| Net Cash Flow from Operations | -9.18M |
| Share Based Compensation | 525.00K |